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A recent genome-wide association study has reported three newly identified susceptible loci (rs2842992 near
the gene SOD2, rs1789110 near the gene MBP and rs722782 near the gene C8orf42) to be associated with the
geographic atrophy subtype of age-related macular degeneration in European-descent population. We investigated
the correlation between these variants and advanced age-related macular degeneration for the first time in a Han
Chinese cohort; however, no evidence supports these previously identified loci contribute to advanced age-related
macular degeneration susceptibility in Chinese population.
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Age-related macular degeneration (AMD) is a late-onset
neurodegenerative disease, which is the major cause of
visual impairment and blindness in adults aged 55 years
or older [1]. AMD is characterized with formation of
choroidal drusen, yellow deposits between the retinal
pigment epithelium (RPE) and underlying choroid in the
early stage. The progression of AMD in an advanced
stage (advanced AMD) can be classified as atrophy of
the RPE (geographic atrophy (GA), or dry AMD), or as
the growth of abnormal choroidal vessels under the ret-
ina (choroidal neovascularization (CNV), or wet AMD)
[2,3]. Previous studies showed that the estimated preva-
lence of advanced AMD was 1.0% in Chinese compared
to 0.6% in Europeans [4] and CNV form was more com-
mon in Chinese individuals [4,5]. Genetic studies often
combined GA and CNV cases as overall advanced AMD
to find the heritable loci and some subgroup analysis
also suggested that these two subtypes of advanced* Correspondence: helin@bio-x.cn; superliuyun@gmail.com
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unless otherwise stated.AMD might share common genetic risk factors [6-10].
Recently, a genome-wide association study (GWAS) has
found several single nucleotide polymorphisms (SNPs) spe-
cifically associated with GA subtype or CNV subtype in
European-descent population [11]. We aimed to investigate
SNPs which were correlated with GA (rs2842992 near
SOD2 (P = 3.4 × 10−7); rs1789110 near MBP (P = 4.2 × 10−7)
and rs722782 near C8orf42 (P = 1.9 × 10−6)) in a Han Chin-
ese cohort, given a sample with higher proportion of GA
subtype (37.7% for GA versus 26.5% for CNV). Due to the
small sample size for each subtype (77 GA cases, 54 CNV
cases and 73 advanced AMD cases lacking of further sub-
type information), we combined the cases as a whole and
analyzed the three SNPs to determine any possible effect
on advanced AMD risk in Chinese population.
204 AMD cases were recruited from the Putuo People’s
Hospital in Zhoushan, China and 384 unrelated healthy
controls were enrolled from the same region. AMD clin-
ical diagnosis was defined strictly in accordance with the
International Classification of Age-Related Maculopathy
and Macular Degeneration [2]. A standard informed con-
sent was established following the guidelines of the
Helsinki Declaration and approved by the ethics commit-
tee of the Shanghai Institute for Biological Sciences.
All the participants obtained and signed the consent.
A demographic summary of the phenotypic information
was shown in Table 1. High-molecular-weight genomic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Characteristics of the participants
Characteristics Case Control
N 204 384
GA subtype (%) 37.7 /
CNV subtype (%) 26.5 /
AMD diagnosis (%)a 35.3 /
Female (%) 44.2 55.9
Age (years) 74.9 ± 7.0 (53–89) 67.6 ± 6.6 (52–86)
Abbreviations: GA geographic atrophy, CNV choroidal neovascularization.
Data are presented as the mean ± standard deviation with range (minimum
to maximum).
aThese cases were diagnosed with AMD, but we could not acquire specific
subtype information.
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phenol-chloroform extraction. The variants of interest
were genotyped by TaqMan SNP genotyping assay (Life
Technologies, Carlsbad, California, USA). Genotype data
were obtained in more than 93% of the DNA samples and
38 replicated quality controls were genotyped with 100%
concordance. We calculated Hardy-Weinberg equilibrium
for each variant based on an exact test [12] and no depar-
tures from the equilibrium were observed in controls
(P > 0.05). We evaluated the association between alleles
and AMD in terms of odds ratios (ORs), 95% confidence
intervals (CIs), and corresponding P values based on
Fisher’s exact test. We further assessed the association be-
tween genotypes and AMD using logistic regression as-
suming an additive model. As we found significant
difference of age distributions between cases and controls
(P < 0.001), we also analyzed the genotypic associations
with adjustment for age. All of the statistical tests were
carried out using the R software package (http://www.
r-project.org/), and a P-value < 0.05 was defined as statis-
tical significance. Statistic powers was post hoc calculated
using the G*Power program, based on goodness-of-fit
test [13].
The allelic and genotypic association results for the se-
lected variants (rs2842992, rs1789110 and rs722782)
were shown in Table 2. We did not find evidence of as-
sociation between these variants and advanced AMD ei-
ther in allele level (P = 0.277 for rs2842992; P = 0.850 for
rs1789110 and P = 0.281 for rs722782) or genotype level
(P = 0.266 for rs2842992; P = 0.798 for rs1789110 and
P = 0.279 for rs722782) in our samples. Even after cor-
rection for age, the associations with advanced AMD
still remained insignificant (P = 0.661 for rs2842992;
P = 0.537 for rs1789110 and P = 0.080 for rs722782).
Moreover, we observed little heterogeneity between GA
cases and non-GA cases as the effective allele frequen-
cies are very close in these two groups (Table 2).
One explanation for the failure to replicate the associ-
ations in our study could be the phenotypic differencebetween GA and CNV of advanced AMD: GA is charac-
terized by the loss of normal RPE cells in a discrete area
of the macula (≥ 175 μm in diameter) with a sharp
border and visible choroidal vessels in the absence of
CNV, which has some clinic aspects in common with
chloroquine retinopathy [14]; while CNV is featured by
haemorrhagic detachment of RPE and presence of sub-
retinal fibrous, with the development of neovascularisa-
tion towards the macula resulting in leaking fluid or
blood [2,3]. As these loci were identified to be associated
with GA alone by Sobrin et al. [11], while we used over-
all advanced AMD which included both GA and CNV
cases, it is possible that the associations were masked by
the phenotypic heterogeneity of mixture of GA and
CNV in our samples. Another explanation for the nega-
tive findings could be the low statistical powers in our
study (21.7% for rs2842992, 5.5% for rs1789110 and
21.4% for rs722782), which indicated inadequate powers
to detect potential associations. However, if the disease
risk could reach a modest effect (OR, 0.70) as reported
by Sobrin et al. [11], we found the sample size had > 90%
power for these variants to detect the association. Further-
more, in previous GWAS study [11], these loci were re-
ported to be highly associated with GA (P values ranging
from 10−6 to 10−7), but none of them reached the gener-
ally used genome-wide threshold (P = 5.0 × 10−8), thus
these loci were only considered as suggestive association
signals by the authors. Meanwhile, the discrepancies of
genetic structures and disease prevalence among popula-
tions may also account for the inconsistency.
Among these three AMD genetic loci (SOD2, MBP
and C8orf42) [11], SOD2 was previously studied with a
common missense variant rs4880 which showed associa-
tions with AMD in Japanese population [15], while this
finding was inconsistent with follow-up studies [16-18].
SOD2 gene encodes a mitochondrial enzyme, which is
involved in the detoxification of superoxide free radicals.
Oxidative damage to the retina, RPE or choroid complex
is implicated for the development of AMD [19,20].
Functional studies demonstrated SOD2 (superoxide
dismutase 2) protects against reactive oxygen species-
induced oxidative damage in mouse RPE [20,21], indicat-
ing a role in AMD pathogenesis. Aside from SOD2,
currently there is no other genetic evidence for MBP
and C8orf42 loci contributing to AMD, and whether
these genes have functional potentiality to AMD patho-
genesis remains to be elucidated.
In summary, the SNPs on genetic loci SOD2, MBP and
C8orf42, which predisposed to GA risk in European
population, were not found significantly associated with
advanced AMD in a Chinese cohort. Additional studies
with larger sample size and more makers are important
to clarify whether these loci confer a risk of overall ad-
vanced AMD or AMD subtypes in Chinese population.
Table 2 Allelic and genotypic associations between three selected SNPs and AMD
SNP information Allelic associations Genotypic associations
dbSNP
ID
Gene chr:pos Location Allelesa Effective allele frequency P valueb Genotypic distributions P valuec P valued
OR (95% CI) OR (95% CI) OR (95% CI)
rs2842992 SOD2 6:160071159 Intergenic A/G Case 0.523 GA case 0.547 0.277 AA/AG/GG Case 47/107/38 0.266 0.661
Control 0.558 Non-GA case 0.508 0.87 (0.67-1.13) Control 109/165/69 0.87 (0.67-1.12) 0.93 (0.68-1.28)
rs1789110 MBP 18:74859044 Intergenic A/C Case 0.542 GA case 0.533 0.850 AA/AC/CC Case 55/107/38 0.798 0.537
Control 0.535 Non-GA case 0.548 1.03 (0.80-1.33) Control 100/171/76 1.03 (0.80-1.33) 1.10 (0.81-1.51)
rs722782 C80rf42 8:516479 Intergenic A/C Case 0.473 GA case 0.471 0.281 AA/AC/CC Case 43/92/53 0.279 0.080
Control 0.508 Non-GA case 0.475 0.87 (0.67-1.12) Control 97/177/91 0.87 (0.68-1.12) 0.76 (0.56-1.03)
Abbreviations: chr:pos chromosome:position, OR odds ratio, CI confidence interval.
aEffective alleles are indicated in bold type, and odds ratios were calculated based on this allele.
bORs, 95% CIs and P values were calculated based on Fisher’s exact test.
cORs, 95% CIs and P values were calculated using logistic regression, assuming the additive model.
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